Gsa Capital Partners LLP Sio Gene Therapies Inc. Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$0.55 - $1.47 $91,743 - $245,204	-166,806 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.29 - $2.36 $329,391 - $602,607	-255,342 Reduced 60.49%	166,806 $215,000
Q3 2021 Nov 12, 2021	BUY	$1.81 - $2.7 $105,452 - $157,304	58,261 Added 16.01%	422,148 $916,000
Q2 2021 Aug 05, 2021	BUY	$2.07 - $2.89 $449,022 - $626,895	216,919 Added 147.6%	363,887 $993,000
Q1 2021 May 10, 2021	SELL	$2.34 - $3.44 $485,074 - $713,101	-207,297 Reduced 58.51%	146,968 $384,000
Q4 2020 Feb 03, 2021	BUY	$1.91 - $5.63 $676,646 - $1.99 Million	354,265 New	354,265 $985,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.